A promoter polymorphism in CD36 is associated with an atherogenic lipid profile in a French general population [3]

Atherosclerosis

Volumn 173, Issue 2, 2004, Pages 373-375

  Leprêtre, Frédéric ^a   Cheyssac, Claire ^a   Amouyel, Philippe ^a,b   Froguel, Philippe ^a,c   Helbecque, Nicole ^a  

^a INSTITUT PASTEUR DE LILLE   (France)

^b LILLE UNIVERSITY HOSPITAL   (France)

^c IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; CD36 ANTIGEN; FLUORESCENT DYE; LIPID;

ANTHROPOMETRY; ATHEROGENESIS; ATHEROSCLEROSIS; BLOOD SAMPLING; CONCENTRATION (PARAMETERS); DISEASE ASSOCIATION; FLUORESCENCE RESONANCE ENERGY TRANSFER; FRANCE; GENE EXPRESSION; GENE FREQUENCY; GENETIC PREDISPOSITION; GENOTYPE; HUMAN; HYPERCHOLESTEROLEMIA; LETTER; MUTATION; NON INSULIN DEPENDENT DIABETES MELLITUS; POPULATION; PRIORITY JOURNAL; PROMOTER REGION; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 1842817584     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2003.12.029     Document Type: Letter

References (7)

1. Febbraio M., Hajjar D.P., Silverstein R.L. CD36: a class B scavenger receptor involved in angiogenesis, atherosclerosis, inflammation, and lipid metabolism. J. Clin. Invest. 108:2001;785-791.
2. Aitman T.J., Glazier A.M., Wallace C.A.et al. Identification of Cd36 (Fat) as an insulin-resistance gene causing defective fatty acid and glucose metabolism in hypertensive rats. Nat. Genet. 21:1999;76-83.
3. Kuniyasu A., Ohgami N., Hayashi S., Miyazaki A., Horiuchi S., Nakayama H. CD36-mediated endocytic uptake of advanced glycation end products (AGE) in mouse 3T3-L1 and human subcutaneous adipocytes. FEBS Lett. 537:2003;85-90.
4. Tsukamoto K., Kinoshita M., Kojima K.et al. Synergically increased expression of CD36, CLA-1 and CD68, but not of SR-A and LOX-1, with the progression to foam cells from macrophages. J. Atheroscler. Thromb. 9:2002;57-64.
5. Kincer J.F., Uittenbogaard A., Dressman J.et al. Hypercholesterolemia promotes a CD36-dependent and endothelial nitric-oxide synthase-mediated vascular dysfunction. J. Biol. Chem. 277:2002;23525-23533.
6. Shaul P.W. Endothelial nitric oxide synthase. J. Physiol. 547:2003;21-33.
7. Yamauchi T., Kamon J., Waki H.et al. The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat. Med. 7:2001;941-946.